美鼎生物(VIVO)

晚点LatePost2022-03-04 16:08

【vivo 砍掉高端手机子品牌 NEX】新浪科技报道，$美鼎生物(VIVO)$ vivo 在今年 2 月的组织调整中撤销了 NEX 事业部。NEX 是 vivo 在 2018 年 6 月推出的高端手机品牌，首款产品起售价近 4000 元，后逐步提升至 5000 元及更高。vivo 副总裁贾净东说，NEX 的定位会转移到公司的旗舰产品 X 系列。
查看全文

长短相形2021-08-18 14:35

$C义翘(SZ301047)$ 昨天买到这个也是意外，鬼使神差的刷到他，发现市盈率很低，火速地瞄了一眼财报，知道了为什么市场给他那么保守的估值，因为他18年19年的业绩并不算好，属于疫情受益。如果是中签的小白不懂得做市场调研的话估计就要把股权白白送人了。
那到底值不值呢？我就又火速的...查看全文

淡泊2582020-12-22 12:14

$美鼎生物(VIVO)$昨天小仓位21.50买入，该股目前已经步入上升趋势，业绩稳定，产品热点，机构重仓，可以长期持有。查看全文

肖恩大侠2020-11-24 10:59

$Cemtrex(CETX)$ 这只俩三月前赚过一波 +50% 就跑了 后来就一直低位徘徊 最近又埋伏了3周 哈哈；美股类似这样的小盘，个别是比较有意思的，产品或模式都有意思，也有潜力；但风险也很大，确实很大；适合配置那么一丁点点，或者极短期。大额配置的，类似之前买过$美鼎生物(VIVO)$ 这样的，因为对业...查看全文

肖恩大侠2020-05-27 23:38

$美鼎生物(VIVO)$ Form 10-Q
Consolidated revenues for the second quarter of fiscal 2020 totaled $57,296, an increase of 14% compared to the second quarter of fiscal 2019 (15% increase on a constant-currency basis).
Revenues for the Diagnostics segment for the second qu...查看全文

肖恩大侠2020-04-08 00:21

$美鼎生物(VIVO)$
1..二季度比预期要好的两位数增长
MERIDIAN BIOSCIENCE ANNOUNCES BETTER-THAN-EXPECTED PRELIMINARY SECOND QUARTER FISCAL 2020 REVENUE RESULTS WITH DOUBLE-DIGIT GROWTH
2.分子诊断，如在冠状病毒类检测业务加速
The Life Science segment achieved record...查看全文

超过5%股东持股披露「修订」

$美鼎生物(VIVO)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-23-010390  Act: 34  Size: 93 KB 网页链接

其他

$美鼎生物(VIVO)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-022599  Act: 33  Size: 35 KB 网页链接

其他

$美鼎生物(VIVO)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-022584  Act: 33  Size: 35 KB 网页链接

其他

$美鼎生物(VIVO)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-022588  Act: 33  Size: 35 KB 网页链接

其他

$美鼎生物(VIVO)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-022594  Act: 33  Size: 35 KB 网页链接

其他

$美鼎生物(VIVO)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-022578  Act: 33  Size: 35 KB 网页链接

其他

$美鼎生物(VIVO)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-022579  Act: 33  Size: 35 KB 网页链接

其他

$美鼎生物(VIVO)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-022572  Act: 33  Size: 35 KB 网页链接

其他

$美鼎生物(VIVO)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-022573  Act: 33  Size: 35 KB 网页链接

其他

$美鼎生物(VIVO)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-022562  Act: 33  Size: 35 KB 网页链接